Abstract Details

Title ITP Following Treatment of Multiple Sclerosis Patients with Alemtuzumab in CAMMS223: Case Reports and Risk Management Plan Implementation

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 004

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Herman C. Sullivan, MD	No disclosure on file
Robert J. Murphy, MD (Neurology Consultants of Kansas)	No disclosure on file
	No disclosure on file

��ɫ��